Clinical Trial Update: Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax [Phase 1]

View source ↗

Summary

Phase I trial updates the use of Tumor Treating Fields in combination with cabozantinib or with pembrolizumab and nab-paclitaxel for various advanced solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Hepatocellular Carcinoma
• Ovarian Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Pembrolizumab (pembrolizumab)
• Tumor Treating Fields (tumor treating fields)
• cabozantinib (cabozantinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Breast Carcinoma, Advanced Endometrial Carcinoma | Phase 1 | Status: RECRUITING